Back to Journals » Vascular Health and Risk Management » Volume 12

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Total article views   HTML views PDF downloads Totals
8,077 Dovepress* 7,433+ 2,038 9,471
PubMed Central* 644 292 936
Totals 8,077 2,330 10,407
*Since 21 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar